Daewoong Pharmaceutical Co., Ltd (KRX:069620)

Daewoong Pharmaceutical Revenue

In the year 2025, Daewoong Pharmaceutical had annual revenue of 1.57T KRW with 10.42% growth. Daewoong Pharmaceutical had revenue of 397.12B in the quarter ending December 31, 2025, with 7.95% growth.

• Revenue: 1.57T
• Revenue Growth: +10.42%
• P/S Ratio: 1.10
• Revenue / Employee: 955.53M
• Employees: 1,644
• Market Cap: 1.72T

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	1.57T	148.21B	10.42%
Dec 31, 2024	1.42T	47.35B	3.44%
Dec 31, 2023	1.38T	95.24B	7.44%
Dec 31, 2022	1.28T	127.12B	11.03%
Dec 31, 2021	1.15T	97.55B	9.24%